$DYN stock has now risen 10% today, according to our price data from Polygon. There has been approximately $27,644,313 of trading volume.
Here is what we see in our data on $DYN (you can track the company live on Quiver's $DYN stock page):$DYN Insider Trading Activity
$DYN insiders have traded $DYN stock on the open market 8 times in the past 6 months. Of those trades, 1 have been purchases and 7 have been sales.
Here’s a breakdown of recent trading of $DYN stock by insiders over the last 6 months:
- JOHN COX (CEO & President) has made 1 purchase buying 100,000 shares for an estimated $911,000 and 2 sales selling 6,700 shares for an estimated $89,603.
- DOUGLAS KERR (Chief Medical Officer) has made 0 purchases and 3 sales selling 5,767 shares for an estimated $76,757.
- JOHANNA FRIEDL-NADERER (Chief Commercial Officer) has made 0 purchases and 2 sales selling 1,038 shares for an estimated $13,794.
To track insider transactions, check out Quiver Quantitative's insider trading dashboard.
$DYN Hedge Fund Activity
We have seen 114 institutional investors add shares of $DYN stock to their portfolio, and 83 decrease their positions in their most recent quarter.
Here are some of the largest recent moves:
- ADAGE CAPITAL PARTNERS GP, L.L.C. added 3,191,000 shares (+inf%) to their portfolio in Q2 2025, for an estimated $30,378,320
- SIREN, L.L.C. added 2,118,450 shares (+77.9%) to their portfolio in Q2 2025, for an estimated $20,167,644
- CITADEL ADVISORS LLC removed 2,065,515 shares (-68.6%) from their portfolio in Q2 2025, for an estimated $19,663,702
- DEEP TRACK CAPITAL, LP removed 2,000,000 shares (-100.0%) from their portfolio in Q2 2025, for an estimated $19,040,000
- SATURN V CAPITAL MANAGEMENT LP added 1,455,429 shares (+inf%) to their portfolio in Q2 2025, for an estimated $13,855,684
- MPM BIOIMPACT LLC added 1,446,361 shares (+inf%) to their portfolio in Q2 2025, for an estimated $13,769,356
- POINT72 ASSET MANAGEMENT, L.P. removed 1,405,250 shares (-91.9%) from their portfolio in Q2 2025, for an estimated $13,377,980
To track hedge funds' stock portfolios, check out Quiver Quantitative's institutional holdings dashboard.
$DYN Analyst Ratings
Wall Street analysts have issued reports on $DYN in the last several months. We have seen 9 firms issue buy ratings on the stock, and 0 firms issue sell ratings.
Here are some recent analyst ratings:
- Stifel issued a "Buy" rating on 07/31/2025
- RBC Capital issued a "Outperform" rating on 07/29/2025
- Chardan Capital issued a "Buy" rating on 07/29/2025
- Raymond James issued a "Outperform" rating on 07/29/2025
- Jones Trading issued a "Buy" rating on 06/26/2025
- Guggenheim issued a "Buy" rating on 06/18/2025
- Baird issued a "Outperform" rating on 06/18/2025
To track analyst ratings and price targets for $DYN, check out Quiver Quantitative's $DYN forecast page.
$DYN Price Targets
Multiple analysts have issued price targets for $DYN recently. We have seen 11 analysts offer price targets for $DYN in the last 6 months, with a median target of $35.0.
Here are some recent targets:
- Martin Auster from Raymond James set a target price of $35.0 on 08/25/2025
- Andreas Argyrides from Oppenheimer set a target price of $13.0 on 08/06/2025
- Paul Matteis from Stifel set a target price of $36.0 on 07/31/2025
- Keay Nakae from Chardan Capital set a target price of $38.0 on 07/29/2025
- Luca Issi from RBC Capital set a target price of $23.0 on 07/29/2025
- Tessa Romero from JP Morgan set a target price of $9.0 on 07/15/2025
- Catherine Novack from Jones Trading set a target price of $30.0 on 06/26/2025
You can track data on $DYN on Quiver Quantitative.
This article is not financial advice. See Quiver Quantitative's disclaimers for more information. Note that there may be inaccuracies due to mistakes in ticker-mapping, and other anomalies.
